Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Man in Taipei injured after taxi slams into 13 vehicles
05/30/2025 03:37 PM - Society
Vietnamese, Taiwanese found guilty, sentenced for heroin trafficking
05/30/2025 01:13 PM - Society
Taiwanese man arrested in South Korea for filming NIS building
05/30/2025 11:35 AM - Society
Sunny, warm weather predicted across Taiwan over long weekend
05/30/2025 10:26 AM - Society
Taiwan headline news
05/30/2025 09:51 AM